Physician profile
Peter J Walter
NPI 1992735377
$1,872,173.23
in general payments reported to CMS, 2019-2025
11 companies · $4,443 in 2025
The $4,443 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218K · 2020: $419K · 2021: $686K · 2022: $443K · 2023: $102K · 2025: $4,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $86K · Travel and Lodging: $12K · Consulting Fee: $7,180 · Food and Beverage: $1,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $85,790.00 |
| Travel and Lodging | $11,603.97 |
| Consulting Fee | $7,180.00 |
| Food and Beverage | $1,811.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,332,164.56 | 2020-2023 | Urolift |
| Neotract INC. | $534,220.47 | 2019-2020 | |
| Calyxo, INC. | $4,442.67 | 2025 | Cvac Aspiration System |
| Teleflex Incorporated | $991.00 | 2019-2020 | |
| Astellas Pharma US INC | $171.55 | 2019-2023 | Xtandi |
| Janssen Biotech, INC. | $58.37 | 2019-2020 | |
| Medtronic USA, INC. | $52.61 | 2019-2020 | |
| Pfizer INC. | $27.84 | 2019 | |
| Dendreon Pharmaceuticals LLC | $20.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.44 | 2019 | |
| Coloplast Corp | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.